Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02191358 · ClinicalTrials.gov registry record
YouScript IMPACT Registry
A clinical trial, sponsored by Genelex Corporation.
- Completed
- Registry status
- 800
- Enrollment target
NCT02191358 is a clinical trial that has completed, run by Genelex Corporation. The registered enrollment target is 800 participants.
The verdict
NCT02191358 has completed, sponsored by Genelex Corporation.
- COMPLETED
- Registry status
- 800 participants
- Enrollment target
Study Summary
This multicenter observational study aims to investigate the benefits of providing pharmacogenetic testing with the YouScript Personalized Prescribing System which includes a clinical decision support tool and individualized pharmacist recommendations to elderly polypharmacy patients who are most at risk of adverse drug events. The YouScript system is unique in identifying drug-gene, and drug-drug-gene interactions that are missed by existing systems, and represent over 35% of significant interaction warnings. Data analysis will assess the impact of recommendations for medication changes on clinical decision making, patient outcomes, and healthcare resource utilization to determine which medications, specialties, or patient segments derive the greatest benefit from this intervention. Data gathered from patients enrolled in this study will be compared to patients matched on key characteristics from Inovalon's MORE2 healthcare database.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2014-10 |
| Est. Completion | 2015-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02191358
The ClinicalTrials.gov registry entry for NCT02191358 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 800 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Genelex Corporation, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02191358 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02191358 about?
NCT02191358 is a clinical study titled "YouScript IMPACT Registry". This multicenter observational study aims to investigate the benefits of providing pharmacogenetic testing with the YouScript Personalized Prescribing System which includes a clinical decision support tool and individualized pharmacist recommendations to elderly polypharmacy patients who are most at...
What is the current status of trial NCT02191358?
This trial is currently completed. The enrollment target is 800 participants. The study started on 2014-10. Estimated completion is 2015-08.
Who is sponsoring clinical trial NCT02191358?
This trial is sponsored by Genelex Corporation, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.